Shanghai Aladdin Biochemical Technology Co. Ltd. Class A
SSSE:68817915.91
CNY
-0.88
(-5.24%)
ISIN
CNE100005XD0
Return %
Stock
S&P 500
1Y
29.24
14.20
3Y
53.79
81.12
5Y
-37.18
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Quarterly Revenue
CNY
•
in mil. unless spec.Quarterly Earnings Per Share
CNY
•
in mil. unless spec.Quarterly Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Jiu Zhen Xu
- Full Time Employees
- 926
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Shanghai China
- IPO Date
- Oct 26, 2020
- Website
- aladdin-e.com
- Similar Companies
- Business
- Shanghai Aladdin Biochemical Technology Co., Ltd. is a China-based manufacturer and distributor of scientific research reagents, life science materials, and laboratory consumables. Founded in 2009 and headquartered in Shanghai, China, the company develops, manufactures, and supplies high-purity scientific research products to academic institutions, universities, biopharmaceutical corporations, medical research laboratories, diagnostic developers, and industrial research and development enterprises across domestic and international markets. The company organizes its business operations across four core product divisions and a comprehensive laboratory consumables line: high-purity chemical reagents, including organic synthesis building blocks, organometallic catalysts, ligands, chemical synthesis reagents, chemical vapor deposition and atomic layer deposition precursors, analytical reference standards, and stable isotope reagents; life science products, comprising recombinant proteins, antibodies, molecular biology kits, cell biology reagents, GMP-grade raw materials for biomanufacturing, cell culture media, buffer components, and bioactive small molecules such as antibody-drug conjugates and proteolysis targeting chimeras; materials science supplies, encompassing electronic chemicals, advanced nanomaterials, battery and energy materials, and biomedical polymer composites; and laboratory consumables and instruments, marketed under its proprietary i-Quip brand, which includes automated and manual liquid handling systems, microcentrifuge tubes, PCR plastics, filtration and chromatography supplies, high-purity glassware, and personal protective laboratory equipment. The company distributes its product portfolio primarily through its integrated e-commerce platform, aladdin-e.com, supported by automated warehousing, regional logistics networks, and cold-chain distribution centers. In recent corporate developments, Shanghai Aladdin has expanded its domestic market footprint and accelerated its global operational presence. In March 2024, the company acquired a 51% controlling equity interest in Shanghai YuanYe Biotechnology Co., Ltd. for approximately RMB 181 million, substantially expanding its life science reagent portfolio, natural product library, and biochemical supply capabilities. To advance international expansion, the company established a direct operational footprint in Europe in late 2024 through its wholly owned subsidiary Aladdin Technology Limited by acquiring a corporate entity in Frankfurt, Germany, to establish localized sales, technical support, and warehousing distribution channels across the European market, complementing its existing overseas presence in North America. Additionally, the company has expanded its research, development, and production capacity with ongoing investments into specialized GMP-certified synthesis facilities and advanced quality testing laboratories.